Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @cbioportal
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @cbioportal
-
It's a small addition, but the new pencil icon allows you to quickly edit and update genes and query criteria (via OQL), in your cBioPortal queries.pic.twitter.com/2OrYhtv0oL
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Looking back as this decade is coming to a close: cBioPortal went from 4 cancer studies to >200, and we added countless new features. Thanks to
#opensource,#TCGA,#NCIITCR,#HTAN,@AACR,@PCF_Science,@SU2C,@BCRFcure. Travel back in time@waybackmachine: https://web.archive.org/web/20110901000000*/cbioportal.org …pic.twitter.com/oVthSoW858
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We have been busy recently releasing new cBioPortal features, thanks to our growing
#opensource community:@sloan_kettering@DanaFarber@ChildrensPhila@pmcancercentre@AstraZeneca@TheHyveNL. Waterfall plots, heatmaps, fusions, filters, quick links etc.: https://www.cbioportal.org/news pic.twitter.com/JDFc895gMU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
cBioPortal proslijedio/la je Tweet
Wait... someone visited
@cBioPortal from Greenland in May!!



pic.twitter.com/EQFSAKEWOb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Looking forward to having PathwayMapper integrated into cBioPortal soon. Great work by
@iVisAtBilkent, with support from@gsoc.https://twitter.com/iVisAtBilkent/status/1184414275588235264 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
New cell line treatment response features in OncoPrints and Plots to drive identification of markers of response/resistance, empowering pre-clinical research in cBioPortal. Thanks to friends in the
@DrySci lab@AstraZeneca especially@KrishnaCBulusu, and our partners@TheHyve.https://twitter.com/TheHyveNL/status/1183647624500527104 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you to all students and mentors who helped make
@gsoc Google Summer of Code 2019 a success! We had 6 projects ranging from visualization prototypes (#clonalevolution#pathwaymapper@OncoKB), to data import pipelines (#CPTAC#GDC) and backend optimizations (#spark#parquet).pic.twitter.com/OaAXgP08DO
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
cBioPortal proslijedio/la je Tweet
Re-upping our job ad for
@cbioportal. Looking for#java#reactjs engineer who wants to learn genomics.#codeforcancer https://careers-dfci.icims.com/jobs/15402/software-engineer%2c-cbioportal-for-cancer-genomics%2c-knowledge-systems-group/job?utm_source=Indeed&utm_medium=organic&utm_campaign=Indeed&mobile=false&width=934&height=500&bga=true&needsRedirect=false&jan1offset=-300&jun1offset=-240 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are trying to get a better sense of local instances of cBioPortal around the world, how they are used, and whether there were any challenges during the installation. If you have a local instance (or tried to install one), please complete this survey: http://bit.ly/2XW3wNG pic.twitter.com/fHN5g1qREs
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
cBioPortal proslijedio/la je Tweet
When it comes to the diagnosis and treatment of cancer, knowledge is key. Find out how UHN is using cBioPortal on Azure to collect genomic and clinical data and improve cancer care with personalized treatment plans: http://msft.social/ENlDzi pic.twitter.com/hMXkQo1OFB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
cBioPortal proslijedio/la je Tweet
New feature: show Genome Aggregation Database (gnomAD) population frequencies in the mutations table (http://bit.ly/2ISHgiu )pic.twitter.com/IfgWuxUEd3
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We added 1350 samples from 3 studies to cBioPortal: Pheochromocytoma and Paraganglioma (TCGA, Cell 2017), Metastatic Solid Cancers (UMich, Nature 2017), and Acute Myeloid Leukemia (OHSU, Nature 2018). Also survival data for TCGA PanCancer Atlas + hypoxia scores for bladder cancerpic.twitter.com/b0mmI7sjY8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are happy to announce a major new feature: Group Comparison. You can now compare clinical and genomic features of user-defined groups of samples or patients. The feature is available on the Study View. Tutorial: https://www.cbioportal.org/tutorials#group-comparison …pic.twitter.com/pn4bXfVYaU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Looking forward to presenting our progress at the 6th Annual
#NCIITCR Investigators Meeting, hosted by@UUtah, this week: New and upcoming features, improved documentation, collaborations with other ITCR groups, etc.@NCIDataSci#NCIITCR19pic.twitter.com/J6N9jkVxdG
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
cBioPortal proslijedio/la je Tweet
Here's our walkthrough/tutorial of our first http://mpcproject.org prostate cancer data release (genomic + clinical) in
@cbioportal for patients, advocates & researchers: https://www.youtube.com/watch?v=7aShLuOpsFE&feature=youtu.be … cc@PCFnews@UsTOOHQ@CancerABCs@ancan501c3@prostatenews@BlueCure@fans4thecureHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We added post-translational modification sites to Mutation Mapper in cBioPortal. You can now see if mutations are in or near PTM sites, including phosphorylation, ubiquitination, acetylation, glycosylation, and other sites. Data from dbPTM. Example here: https://www.cbioportal.org/results/mutations?session_id=5cd30f98e4b0f85699098598 …pic.twitter.com/kedSpCntlF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Data from more than 500 samples in four new studies are now available in cBioPortal, including an updated data set of metastatic prostate cancer from the
@PCFnews /@SU2C Dream Team, just published in@PNASNews. https://www.pnas.org/content/early/2019/04/30/1902651116.abstract …pic.twitter.com/0515VNWLb4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beta version of our new quick search for cBioPortal is now up. Enables you to more easily jump to your favorite gene or study of interest. Let us know what you think!pic.twitter.com/CDO5let1M5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
cBioPortal proslijedio/la je Tweet
Looking forward to presenting
@cbioportal at#AACR19 4:20pm today/Sunday on behave of our dev team, and discussing with developers of other great tools for cancer genomics, COSMIC, Xena, and others!pic.twitter.com/kyNJBrZ3Pp
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
cBioPortal proslijedio/la je Tweet
Learning the evolution of CBioportal
#precisiononcology effort by team@MSKCC_OncoNotes by Dr Solit. Exciting. Thank you for your effort - I use it everyday!!!#AACR19pic.twitter.com/vsp478zBnr
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.